NICE SUGAR: Intensive insulin therapy risks

March 24, 2009

OTTAWA, ONTARIO, CANADA - Intensive insulin therapy significantly increases the risk of hypoglycemia in critically ill patients, found a new study in CMAJ (http://www.cmaj.ca/press/cmaj.090206.pdf).

Intensive insulin therapy is used in many intensive care units around the world as a means to tightly regulate blood sugar. Although labour intensive, it has been recommended as a standard of care for critically ill patients by many organizations including the American Diabetes Association and the American Association of Clinical Endocrinologists.

A randomized trial in 2001 reported that intensive insulin therapy significantly reduced hospital mortality, although subsequent trials have reported inconsistent effects on mortality and higher rates of severe hypoglycemia.

The CMAJ study includes data from 26 trials, including the NICE-SUGAR Study on intensive insulin therapy, an international, multicentre randomized trial that is the largest intensive insulin therapy trial to date. The NICE-SUGAR study is published online in the New England Journal of Medicine March 24, 2009 and March 26 for the print edition.

"By including the largest trial on intensive insulin therapy published to date, we provide the most current and precise estimate of the effect of intensive insulin therapy on vital status and hypoglycemia in the ICU setting," write Dr. Donald Griesdale, anesthesiologist and critical care physician at Vancouver General Hospital and clinical instructor at the University of British Columbia, and coauthors.

The CMAJ study looked at 26 trials involving 13 567 patients. There was a 6-fold increased risk of hypoglycemia compared to the control treatment.

The study was conducted by researchers from the University of British Columbia and Vancouver General Hospital, Vancouver, BC; Harvard School of Public Health, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Boston, Mass; Queen's University and Kingston General Hospital, Kingston, Ontario; McMaster University, Hamilton, Ontario; Royal North Shore Hospital and the University of Sydney, Australia.

"We suggest that policy makers reconsider recommendations promoting the use of intensive insulin therapy in all critically ill patients," write the authors. However, because the study included data from trials in different populations with varied illness severity, they "cannot exclude the possibility that some patients may benefit from intensive insulin therapy and be at less risk of hypoglycemic events."

In a related commentary (http://www.cmaj.ca/press/cmaj.090500.pdf), Dr. Greet Van den Berghe and colleagues argue that differences in specific elements of how intensive insulin therapy was delivered account for the varying findings of individual studies and that a single guideline for intensive insulin therapy applicable to all patients is not appropriate.
-end-
Media contact: Kim Barnhardt, CMAJ, 1-800-663-7336 or 613-731-8610 ext. 2224, kim.barnhardt@cmaj.ca

Canadian Medical Association Journal

Related Hypoglycemia Articles from Brightsurf:

Novel therapy approach for hyperinsulinemic hypoglycemia
A new method to treat hyperinsulinemic hypoglycemia has proven highly selective in targeting lesions and effective in slowing tumor growth, according to research published in the November issue of the Journal of Nuclear Medicine.

Artificial pancreas can prevent dangerously low blood sugar in people with T1D
A new artificial pancreas system can prevent hypoglycemia--episodes of dangerously low blood sugar--during and after heavy exercise in people with type 1 diabetes, according to a small study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Continuous glucose monitoring reduces hypoglycemia in older adults with type 1 diabetes
Laura Young, MD, PhD, associate professor of medicine, was UNC's principal investigator for this six-month clinical trial that shows the use of continuous glucose monitoring (CGM) reduces serious levels of hypoglycemia compared with standard monitoring by daily use of blood glucose finger-stick test strips.

Understanding unexplained low blood sugar in children: More than normal variation
Idiopathic ketotic hypoglycemia (IKH) is often relatively mild and may remain undiagnosed.

New closed-loop system offers promise as novel treatment for post-bariatric hypoglycemia
Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation.

First-ever quality measures aim to reduce diabetes complications
The Endocrine Society and Avalere Health introduced the first-ever quality measures to help healthcare providers assess how well they identify and care for older adults at greater risk of hypoglycemia -- low blood sugar that can be a dangerous complication of diabetes treatment.

Meal type and size are the key factors affecting carb-counting in type 1 diabetes
Meal type and size are the most important factors influencing the accuracy of carb-counting for the control of blood sugar in type 1 diabetes, according to new research being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Spain (Sept.

Popular pain medication associated with greater risk of hypoglycemia
As the opioid tramadol has grown in popularity so too have documented cases of adverse effects.

Too much of a good thing can be dangerous, finds researchers investigating hypoglycemia
For people with diabetes, taking medications and monitoring their blood sugar is part of the rhythm of their daily lives.

Researchers create model to predict risk of low blood sugar in people with diabetes
A new study by researchers from Regenstrief Institute and Merck identifies the risk factors that could help healthcare providers recognize patients being treated for diabetes who are most likely to have low blood sugar.

Read More: Hypoglycemia News and Hypoglycemia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.